Shandong Yanggu Huatai Chemical Co., Ltd. (300121.SZ)
Liaocheng, CN
Founded in 1994 and headquartered in Liaocheng, China, Shandong Yanggu Huatai Chemical Co., Ltd. operates within the rubber chemicals sector. The company manufactures a comprehensive range of products, including standard and pre-dispersed rubber compounds, insoluble sulfur, various processing aids, rubber protective waxes, and resins. They also provide specialized additive systems for vulcanization, adhesion, processing, predispersion, and anti-aging purposes. Among their specific chemical offerings are rubber anti-scorcher CTP and accelerators such as NS, CBS, and M. Additionally, the company is involved in the international trade of rubber chemicals, managing both imports and exports.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.53% | -12.46% | -10.54% | -20.59% | -22.54% | -12.60% | -21.21% | +16.60% | -19.49% | +13.36% | +91.16% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+0.0% Q1'26: -0.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-4.3% Q1'26: +0.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+3.6% Q1'26: +0.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.9% ★ Q1'26: +11.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+5.7% ★ Q1'26: +7.8% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+7.3% Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.12× ★ Q1'26: 1.51× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
860.03M
est: 860.00M (+0.0%)
|
1.24B
est: 1.16B (+6.8%)
|
1.64B
est: 1.61B (+1.8%)
|
2.08B
est: 2.14B (-2.9%)
|
2.01B
est: 2.49B (-19.0%)
|
1.94B
est: 2.12B (-8.4%)
|
2.78B
est.
|
2.71B
est: 3.47B (-22.0%)
|
3.52B
est: 3.63B (-3.0%)
|
3.45B
est: 3.63B (-4.8%)
|
3.43B
est: 4.79B (-28.4%)
|
3.43B
est: 3.88B (-11.6%)
|
3.87B
3.87B – 3.87B
-0.2% YoY
|
4.21B
4.21B – 4.21B
+8.6% YoY
|
4.58B
4.58B – 4.58B
+8.8% YoY
|
| EBITDA |
148.61M
est: 142.21M (+4.5%)
|
284.94M
est: 191.99M (+48.4%)
|
337.27M
est: 266.16M (+26.7%)
|
543.48M
est: 354.67M (+53.2%)
|
307.87M
est: 411.06M (-25.1%)
|
257.37M
est: 350.96M (-26.7%)
|
459.46M
est.
|
484.97M
est: 573.48M (-15.4%)
|
775.70M
est: 599.84M (+29.3%)
|
559.58M
est: 599.84M (-6.7%)
|
465.88M
est: 805.48M (-42.2%)
|
488.89M
est: 651.91M (-25.0%)
|
650.40M
650.40M – 650.40M
-0.2% YoY
|
706.51M
706.51M – 706.51M
+8.6% YoY
|
769.02M
769.02M – 769.02M
+8.8% YoY
|
| EBIT |
90.69M
est: 103.44M (-12.3%)
|
227.01M
est: 139.65M (+62.6%)
|
278.79M
est: 193.60M (+44.0%)
|
477.90M
est: 257.98M (+85.2%)
|
234.59M
est: 299.00M (-21.5%)
|
168.77M
est: 255.29M (-33.9%)
|
334.21M
est.
|
367.98M
est: 417.15M (-11.8%)
|
644.49M
est: 436.32M (+47.7%)
|
409.73M
est: 436.32M (-6.1%)
|
280.58M
est: 573.71M (-51.1%)
|
270.06M
est: 464.33M (-41.8%)
|
463.26M
463.26M – 463.26M
-0.2% YoY
|
503.23M
503.23M – 503.23M
+8.6% YoY
|
547.74M
547.74M – 547.74M
+8.8% YoY
|
| Net Income |
39.31M
est: 47.21M (-16.7%)
|
156.78M
est: 199.71M (-21.5%)
|
203.54M
est: 243.82M (-16.5%)
|
367.25M
est: 449.66M (-18.3%)
|
184.35M
est: 269.79M (-31.7%)
|
125.78M
est: 273.88M (-54.1%)
|
416.96M
est.
|
283.92M
est: 555.94M (-48.9%)
|
515.39M
est: 371.99M (+38.5%)
|
304.30M
est: 371.99M (-18.2%)
|
192.13M
est: 570.11M (-66.3%)
|
197.34M
est: 267.51M (-26.2%)
|
267.51M
267.51M – 267.51M
+0.0% YoY
|
333.29M
333.29M – 333.29M
+24.6% YoY
|
385.92M
385.92M – 385.92M
+15.8% YoY
|
| SGA |
112.23M
est: 27.12M (+313.8%)
|
117.84M
est: 36.62M (+221.8%)
|
129.59M
est: 50.76M (+155.3%)
|
165.96M
est: 67.64M (+145.3%)
|
200.19M
est: 78.40M (+155.3%)
|
144.75M
est: 66.94M (+116.3%)
|
87.63M
est.
|
167.77M
est: 109.38M (+53.4%)
|
256.30M
est: 114.40M (+124.0%)
|
246.95M
est: 114.40M (+115.9%)
|
238.84M
est: 288.97M (-17.3%)
|
87.15M
est: 233.88M (-62.7%)
|
233.34M
233.34M – 233.34M
-0.2% YoY
|
253.47M
253.47M – 253.47M
+8.6% YoY
|
275.89M
275.89M – 275.89M
+8.8% YoY
|
| EPS |
0.14
est: 0.12 (+21.2%)
|
0.56
est: 0.49 (+14.6%)
|
0.65
est: 0.60 (+9.0%)
|
1.01
est: 1.10 (-8.2%)
|
0.47
est: 0.66 (-28.8%)
|
0.34
est: 0.67 (-49.3%)
|
1.02
est.
|
0.77
est: 1.36 (-43.4%)
|
1.34
est: 0.91 (+47.3%)
|
0.75
est: 0.91 (-17.6%)
|
0.47
est: 1.30 (-63.8%)
|
0.45
est: 0.61 (-26.2%)
|
0.61
0.61 – 0.61
+0.0% YoY
|
0.76
0.76 – 0.76
+24.6% YoY
|
0.88
0.88 – 0.88
+15.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bingzhu Liu | Deputy GM & Non-Independent Director | — | male |
| Chao Wang | Deputy GM & Secretary | — | male |
| Delong Ma | Deputy GM & Non-Independent Director | — | male |
| Feng Bao Zhao | Deputy General Manager | — | male |
| Wenbo Wang | GM & Chairman of the Board | — | male |
| Xian Wei Chen | Deputy General Manager | — | male |
| Xue Lian Wei | Accounting Supervisor | — | — |
| Yuguang He | Chief Financial Officer & Deputy GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300121.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
